Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
2.000
-0.250 (-11.11%)
At close: Aug 16, 2024, 4:00 PM
2.080
+0.080 (4.00%)
After-hours: Aug 16, 2024, 7:59 PM EDT
Citius Oncology Statistics
Total Valuation
CTOR has a market cap or net worth of $151.20 million.
Market Cap | 151.20M |
Enterprise Value | n/a |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CTOR has 75.60 million shares outstanding. The number of shares has increased by 100.00% in one year.
Shares Outstanding | 75.60M |
Shares Change (YoY) | +100.00% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 9.97M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 6.80 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.32
Current Ratio | 0.32 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CTOR has paid $576,000 in taxes.
Income Tax | 576,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.26% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -81.26% |
50-Day Moving Average | 14.03 |
200-Day Moving Average | 11.78 |
Relative Strength Index (RSI) | 33.20 |
Average Volume (20 Days) | 393,030 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.90M |
Pretax Income | n/a |
Net Income | -17.48M |
EBITDA | n/a |
EBIT | -16.90M |
Earnings Per Share (EPS) | -$0.26 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Net Cash Per Share | n/a |
Equity (Book Value) | 19.85M |
Book Value Per Share | 0.29 |
Working Capital | -18.71M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CTOR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -100.00% |
Shareholder Yield | -100.00% |
Earnings Yield | -11.56% |
FCF Yield | n/a |
Analyst Forecast
The average price target for CTOR is $6.00, which is 200.00% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $6.00 |
Price Target Difference | 200.00% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |